Paper24671700
Fibrin clot properties and their modulation in thrombotic disorders.
Undas A. Thromb Haemost, 2014. Cited by 118 papers, by iCite.
Cite this record
ConductScience Library. Fibrin clot properties and their modulation in thrombotic disorders. Papers, record 24671700. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24671700
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibrin | Major topic |
| Myocardial Infarction | Major topic |
| Stroke | Major topic |
| Thrombolytic Therapy | Major topic |
| Venous Thromboembolism | Major topic |
| Animals | |
| Blood Coagulation | |
| Humans |
Source PubMed
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 118 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41326508 | U shaped association between fibrinogen and one year mortality in women undergoing coronary artery bypass grafting. | Sci Rep | 2025 | https://conductscience.org/library/papers/41326508 | PubMed |
| 41110513 | Hypoalbuminemia increases fibrin clot density and impairs fibrinolysis. | J Thromb Haemost | 2026 | https://conductscience.org/library/papers/41110513 | PubMed |
| 40298646 | Fibrinogen Oxidation and Thrombosis: Shaping Structure and Function. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/40298646 | PubMed |
| 39765785 | Fibrinogen Structural Changes and Their Potential Role in Endometriosis-Related Thrombosis. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39765785 | PubMed |
| 39477884 | Post-translational modifications of fibrinogen: implications for clotting, fibrin structure and degradation. | Mol Biomed | 2024 | https://conductscience.org/library/papers/39477884 | PubMed |
| 39395704 | Rupture mechanics of blood clots: Influence of fibrin network structure on the rupture resistance. | Acta Biomater | 2024 | https://conductscience.org/library/papers/39395704 | PubMed |
| 39180244 | Fibrinogen post-translational modifications are biochemical determinants of fibrin clot properties and interactions. | FEBS J | 2025 | https://conductscience.org/library/papers/39180244 | PubMed |
| 38931548 | Advancing Thrombosis Research: A Novel Device for Measuring Clot Permeability. | Sensors (Basel) | 2024 | https://conductscience.org/library/papers/38931548 | PubMed |
| 38686609 | Mechanics and microstructure of blood plasma clots in shear driven rupture. | Soft Matter | 2024 | https://conductscience.org/library/papers/38686609 | PubMed |
| 38672245 | Fibrinaloid Microclots and Atrial Fibrillation. | Biomedicines | 2024 | https://conductscience.org/library/papers/38672245 | PubMed |
| 38649560 | Overall haemostatic potential assay for prediction of outcomes in venous and arterial thrombosis and thrombo-inflammatory diseases. | J Thromb Thrombolysis | 2024 | https://conductscience.org/library/papers/38649560 | PubMed |
| 38473289 | Blood Clot Dynamics and Fibrinolysis Impairment in Cancer: The Role of Plasma Histones and DNA. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38473289 | PubMed |
| 37719941 | Fibrinogen is Associated with Clinical Adverse Events in Patients with Psoriasis and Coronary Artery Disease. | J Inflamm Res | 2023 | https://conductscience.org/library/papers/37719941 | PubMed |
| 37201530 | Antithrombin Deficiency Is Associated with Prothrombotic Plasma Fibrin Clot Phenotype. | Thromb Haemost | 2023 | https://conductscience.org/library/papers/37201530 | PubMed |
| 35483911 | An in vitro model for Extracellular DNA Traps (ETs)-rich Human Thrombus Analogs. | J Neurointerv Surg | 2023 | https://conductscience.org/library/papers/35483911 | PubMed |
| 34702844 | Accelerated fibrin clot degradation is associated with arterial thromboembolism in patients following venous thrombosis: a cohort study. | Sci Rep | 2021 | https://conductscience.org/library/papers/34702844 | PubMed |
| 34683859 | Acoustic and Elastic Properties of a Blood Clot during Microbubble-Enhanced Sonothrombolysis: Hardening of the Clot with Inertial Cavitation. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34683859 | PubMed |
| 34279484 | Fibrin Clot Properties in Atherosclerotic Vascular Disease: From Pathophysiology to Clinical Outcomes. | J Clin Med | 2021 | https://conductscience.org/library/papers/34279484 | PubMed |
| 33804303 | Precision Treatment in ACS-Role of Assessing Fibrinolysis. | J Clin Med | 2021 | https://conductscience.org/library/papers/33804303 | PubMed |
| 33424834 | Detection of Citrullinated Fibrin in Plasma Clots of Rheumatoid Arthritis Patients and Its Relation to Altered Structural Clot Properties, Disease-Related Inflammation and Prothrombotic Tendency. | Front Immunol | 2020 | https://conductscience.org/library/papers/33424834 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PLG | 5340 | PubTator's text mining | https://conductscience.org/library/genes/5340 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24671700
GET https://conductscience.org/api/papers/v1/24671700/cited_by?page=2